PANCREATIC ACINAR CELL CARCINOMA
Clinical trials for PANCREATIC ACINAR CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC ACINAR CELL CARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC ACINAR CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control many different types of rare, advanced cancers that have limited treatment options. It enrolled over 800 adults whose cancer progressed after standard therapy. The g…
Matched conditions: PANCREATIC ACINAR CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 05:21 UTC
-
New 3-Drug chemo cocktail enters Late-Stage trial for Tough-to-Treat pancreatic cancer
Disease control OngoingThis study is for people whose advanced pancreatic cancer has spread and has a specific genetic change (BRCA1, BRCA2, or PALB2 mutation). It compares a new three-drug chemotherapy combination (NABPLAGEM) against the current standard two-drug combination. The goal is to see if add…
Matched conditions: PANCREATIC ACINAR CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Apr 04, 2026 05:20 UTC
-
Scientists test new drug cocktail in fight against tough pancreatic cancers
Disease control OngoingThis early-stage study is testing the safety and best doses of a combination of two or three drugs (vismodegib, erlotinib, and sometimes gemcitabine) in people with advanced pancreatic cancer or other solid tumors that cannot be removed by surgery. The goal is to see if blocking …
Matched conditions: PANCREATIC ACINAR CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
First-in-Human trial tests direct tumor injection to fight deadly pancreatic cancer
Disease control OngoingThis early-stage study is testing a new vaccine therapy for people with advanced pancreatic cancer that cannot be removed by surgery. The goal is to find a safe dose and see if injecting the vaccine directly into the tumor, along with an immune-boosting drug, can help the body's …
Matched conditions: PANCREATIC ACINAR CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC